Prevalence, causes, and clinical associations of anemia in patients with systemic sclerosis: A cohort study

被引:0
|
作者
Gachet, Benoit [1 ,2 ,3 ]
Jouvray, Mathieu [1 ,4 ]
Koether, Vincent [1 ,5 ,6 ]
Collet, Aurore [5 ,6 ,7 ]
Morell-Dubois, Sandrine [1 ]
Sanges, Sebastien [1 ,5 ,6 ]
Sobanski, Vincent [1 ,5 ,6 ]
Hachulla, Eric [1 ,5 ,6 ]
Launay, David [1 ,5 ,6 ,8 ]
机构
[1] CHU Lille, Dept Internal Med & Clin Immunol, Lille, France
[2] Univ Lille, CH Tourcoing,ULR 2694, Dept Biostat, METR Evaluat Technol Sante & Prat Med, Lille, France
[3] Gustave Dron Hosp, Infect Dis Unit, Tourcoing, France
[4] CH Arras, Serv Med Interne, Arras, France
[5] Univ Lille, Inst Translat Res Inflammat, U1286, INFINITE, Lille, France
[6] INSERM, Lille, France
[7] CHU Lille, Inst Immunol, Pole Biol Pathol Genet Medicale, Lille, France
[8] CHU Lille, Serv Med Interne & Immunol Clin, 1 Pl Verdun, F-59045 Lille, France
关键词
Systemic sclerosis; anemia; iron deficiency; survival; ACTIVITY CRITERIA; SCLERODERMA; CLASSIFICATION; SURVIVAL; FEATURES;
D O I
10.1177/23971983241238921
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Anemia is considered a risk factor of severity in systemic sclerosis. Yet, limited data are available on the frequency and causes of anemia in systemic sclerosis. The objectives of our study were to determine the frequency and causes of anemia in systemic sclerosis, to analyze the clinical and biological characteristics of patients with anemia, and to assess the association between anemia and systemic sclerosis prognosis. Methods: We conducted a prospective single-center study from January 2017 to May 2022. Patients underwent a hemoglobin assay and a standardized etiological workup to determine the causes of anemia at the initial visit. Clinical and biological parameters were compared between patients with anemia and those with normal hemoglobin levels. We followed up patients until May 2023 and compared their survival. Results: A total of 502 systemic sclerosis patients, including 107 diffuse cutaneous systemic sclerosis, were included. At enrollment, 100 patients had anemia. The primary cause of anemia was iron deficiency (40%). Among the 32 patients with iron deficiency-associated anemia who underwent gastrointestinal exploration, 56% had digestive bleeding, with upper gastrointestinal tract involvement being the main cause (90%). Patients with anemia at enrollment had higher systemic sclerosis severity scores and more gastrointestinal symptoms compared to patients without anemia (p < 0.05). They exhibited higher systolic pulmonary artery pressure, lower anemia-corrected diffusing capacity for carbon monoxide, and lower forced vital capacity (p < 0.05). During follow-up, 65 patients (14.8%) died. After adjusting for age, systemic sclerosis subtypes, forced vital capacity, and pulmonary arterial hypertension, anemia at inclusion was associated with a higher mortality rate (hazard ratio: 1.94 (95% confidence interval: 1.39-2.48), p = 0.02). Conclusion: Our study shows a high frequency of anemia among patients with systemic sclerosis. Most anemias are due to iron deficiency, and gastrointestinal exploration can identify bleeding in the majority of the cases. In addition, our study confirms that systemic sclerosis patients with anemia have a more severe disease and a higher mortality rate.
引用
收藏
页码:203 / 209
页数:7
相关论文
共 50 条
  • [21] Causes of death, survival and risk factors of mortality in Thai patients with early systemic sclerosis: inception cohort study
    Suparaporn Wangkaew
    Narawudt Prasertwitayakij
    Arintaya Phrommintikul
    Saowanee Puntana
    Juntima Euathrongchit
    Rheumatology International, 2017, 37 : 2087 - 2094
  • [22] Restless legs syndrome in patients with systemic sclerosis Prevalence and possible causes
    Ostojic, P.
    Jovic, T.
    Stojic, B.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 (06): : 590 - 593
  • [23] Survival rate, causes of death, and risk factors in systemic sclerosis: a large cohort study
    Xue Li
    Yu-quan Qian
    Na Liu
    Rong Mu
    Yu Zuo
    Guo-chun Wang
    Yuan Jia
    Zhan-guo Li
    Clinical Rheumatology, 2018, 37 : 3051 - 3056
  • [24] Causes and predictors of death among Finnish patients with systemic sclerosis
    Kortelainen, S.
    Kayra, M.
    Rissanen, T.
    Paltta, J.
    Taimen, K.
    Pirila, L.
    Huhtakangas, J.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2024, 53 (04) : 269 - 275
  • [25] Prediction of progressive fibrosing interstitial lung disease in patients with systemic sclerosis: insight from the CRDC cohort study
    Hui, Min
    Duan, Xinwang
    Zhou, Jiaxin
    Li, Mengtao
    Wang, Qian
    Zhao, Jiuliang
    Hou, Yong
    Xu, Dong
    Zeng, Xiaofeng
    RMD OPEN, 2024, 10 (01):
  • [26] First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort study
    Rubio-Rivas, Manuel
    Corbella, Xavier
    Pestana-Fernandez, Melany
    Tolosa-Vilella, Carles
    Guillen-del Castillo, Alfredo
    Colunga-Arguelles, Dolores
    Trapiella-Martinez, Luis
    Iniesta-Arandia, Nerea
    Jesus Castillo-Palma, Maria
    Saez-Comet, Luis
    Victoria Egurbide-Arberas, Maria
    Ortego-Centeno, Norberto
    Freire, Mayka
    Antonio Vargas-Hitos, Jose
    Jose Rios-Blanco, Juan
    Antonio Todoli-Parra, Jose
    Rodriguez-Carballeira, Monica
    Marin-Ballve, Adela
    Segovia-Alonso, Pablo
    Pla-Salas, Xavier
    Belen Madronero-Vuelta, Ana
    Ruiz-Munoz, Manuel
    Fonollosa-Pla, Vicent
    Pilar Simeon-Aznar, Carmen
    Callejas Moraga, E.
    Calvo, E.
    Carbonell, C.
    Castillo, M. J.
    Chamorro, A. J.
    Colunga, D.
    Corbella, X.
    Egurbide, M. V.
    Espinosa, G.
    Fonollosa, V.
    Freire, M.
    Garcia Hernandez, F. J.
    Gonzalez Leon, R.
    Guillen del Castillo, A.
    Iniesta, N.
    Lorenzo, R.
    Madronero, A. B.
    Mari, B.
    Marin, A.
    Ortego-Centeno, N.
    Perez Conesa, M.
    Pestana, M.
    Pla, X.
    Rios Blanco, J. J.
    Rodriguez Carballeira, M.
    Rubio Rivas, M.
    CLINICAL RHEUMATOLOGY, 2018, 37 (04) : 999 - 1009
  • [27] An analysis of the relationship between autoantibodies and clinical findings in patients with systemic sclerosis
    Yayla, Mucteba Enes
    Ilgen, Ufuk
    Duzgun, Nursen
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2018, 48 (01) : 10 - 15
  • [28] Differences in presentation of younger and older systemic sclerosis patients in clinical trials
    Weng, H. H.
    Ranganath, V. K.
    Oh, M.
    Park, G. S.
    Khanna, D.
    Clements, P. J.
    Seibold, J. R.
    Elashoff, D. A.
    Furst, D. E.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (05) : S10 - S14
  • [29] Survival, Causes of Death, and Risk Factors Associated With Mortality in Spanish Systemic Sclerosis Patients: Results From a Single University Hospital
    Joven, Beatriz E.
    Almodovar, Raquel
    Carmona, Loreto
    Carreira, Patricia E.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2010, 39 (04) : 285 - 293
  • [30] Screening of pulmonary hypertension in a Spanish cohort of patients with systemic sclerosis
    Garcia Hernandez, Francisco Jose
    Castillo Palma, Maria Jesus
    Montero Mateos, Enrique
    Gonzalez Leon, Rocio
    Lopez Haldon, Jose Eduardo
    Sanchez Roman, Julio
    MEDICINA CLINICA, 2016, 146 (01): : 1 - 7